Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Differential effects of caffeine, acute aerobic exercise, and placebo on mental fatigue

  • Ali Shirzad ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing

    ashirza@uwo.ca

    Current Address: Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

    Affiliations Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

  • Nathan Frewen,

    Roles Data curation, Investigation, Writing – review & editing

    Current Address: Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

    Affiliation Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

  • Anisa Morava,

    Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

  • Nader Elshawish,

    Roles Conceptualization, Methodology, Writing – review & editing

    Affiliation Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  • Harry Prapavessis

    Roles Funding acquisition, Project administration, Supervision, Writing – review & editing

    Current Address: Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

    Affiliation Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada

Abstract

Mental fatigue negatively affects the productivity and health of the general population. Mental fatigue manifests following sustained mental activity and is defined by subjective feelings of inhibition and objective decrements in mental performance. Caffeine is one of the most common stimulants used to mitigate mental fatigue. However, regular caffeine consumption may be associated with several side effects and potential dependence. The efficacy of acute aerobic exercise as an alternative mental fatigue intervention remains ambiguous. Thus, the present study utilized a randomized crossover design to compare the efficacy of the three treatments in mitigating mental fatigue in 26 adult caffeine consumers. The three treatments included: 1) 20 minutes of moderate-intensity cycling, 2) consumption of 2.5 mg/kg of caffeine, and 3) consumption of placebo (0.67 g corn starch). Treatments were administered prior to a mental fatigue-induction task (30-minute Stroop task). Participants and the experimenter were both blinded to the administration of caffeine or placebo. Objective (Psychomotor Vigilance Task) and subjective (visual analog scales) mental fatigue measures were taken prior to and following the mental fatigue-induction task. We hypothesized that in the placebo condition, participants would demonstrate greater mental fatigue following a 30-minute Stroop task relative to baseline. Further, mental fatigue induction will be mitigated in the acute exercise and caffeine consumption conditions to a similar degree. Participants reported significantly greater mental fatigue following a 30-minute Stroop task (p < 0.001, d = −0.735). Comparison of the placebo and caffeine consumption did not exhibit a reliable difference (all p’s > 0.05). Contrary to our hypothesis, mental fatigue was not mitigated following acute exercise (p = 0.499). Further investigations are warranted to explore the potential of varying exercise intensities and durations in mitigating mental fatigue.

Introduction

Fatigue is a multidimensional concept, commonly understood as feelings of tiredness and difficulty in initiating or sustaining voluntary activity following prolonged mental or physical activity [1]. Fatigue is often characterized by its subjective experience and effects on task performance [2]. Specifically, fatigue that manifests as cognitive impairment is known as mental fatigue [3]. Accruing mental fatigue through sustained mental activity can be specifically defined as “a gradual and cumulative process … associated with a disinclination for any effort, a general sensation of weariness, feelings of inhibition and impaired mental performance, reduced efficiency and alertness” [4]. Indeed, mental fatigue has been shown to disrupt several cognitive processes including attention, planning, decision-making, inhibitory control, and memory [58]. The feeling of mental fatigue (i.e., subjective fatigue) may fluctuate independent of task performance (i.e., objective fatigue); thus, it is important to measure both constructs [9,10]. Approximately 50% of U.S. adults report experiencing moderate-to-severe fatigue throughout the course of a week [11]. Though fatigue is widely accepted as a part of daily life, it has been associated with several unwanted outcomes. For example, fatigue in U.S. workers has been estimated to account for “an excess of $101.0 billion” in lost productive time annually [12]. Further, one of the most prevalent symptoms affecting individuals seeking primary care is fatigue, which is thought to “account for 10 million office visits a year in the [U.S.]” [13]. Thus, interventions to mitigate fatigue are necessary to support the overall productivity and health of the general population.

Caffeine (1,3,7-trimethylxanthine) consumption reliably mitigates mental fatigue [1417]. Caffeine exerts this effect on the central nervous system through antagonism of central adenosine receptors [18]. Approximately 89% of adults in the U.S. consume caffeine regularly [19]. Moreover, daily caffeine consumption among adults has been estimated to be between 1.7–2.9 mg/kg [20]. Past research has also demonstrated the beneficial effects of caffeine consumption on alertness, mood, attention, and cognitive task performance [2124]. Although the benefits of caffeine consumption are well-documented, these may be concurrent with several undesirable side effects. Acute side effects of caffeine consumption include anxiety, muscle tremors, and gastrointestinal distress [2527]. Further, habitual caffeine consumption has been associated with withdrawal symptoms including fatigue, headache, nausea, and depressed mood, which may manifest after 12–24 hours of caffeine deprivation [2830]. Several authors have suggested that caffeine dependence can develop after habitual, high-dosage use [31,32]. However, the formal inclusion of caffeine substance use order in diagnostic manuals such as the DSM is an area of active contention [33,34].

Altogether, a large body of evidence suggests caffeine usage, although effective in mitigating mental fatigue, may result in side effects and potential dependence. Thus, it is important to explore alternative methods for mitigating mental fatigue. Past research has amply demonstrated that a single bout of aerobic exercise (i.e., acute aerobic exercise) can enhance cognitive function [3538]. Additionally, work by Morava and colleagues [39] suggests that acute moderate-intensity aerobic exercise may reduce caffeine withdrawal symptoms. Therefore, acute aerobic exercise may be a promising alternative to caffeine consumption; however, its effects on mental fatigue are unclear. To our knowledge, no prior studies have directly compared caffeine and aerobic exercise as fatigue-mitigation strategies. Thus, the present exploratory study was designed to evaluate their individual effects before exploring potential combined interventions in future work.

Two mechanisms that potentially underlie acute exercise benefits to cognitive function are: 1) increased cerebral blood flow (CBF), and 2) the modulation of neurotransmitter concentrations [4042]. Increases in CBF following exercise have been well-documented and are thought to arise from neurovascular coupling, increased CO2 production, and increased systolic blood pressure (BP) [43,44]. Furthermore, production of several neurotransmitters has been suggested to increase in response to acute aerobic exercise, including dopamine, noradrenaline, adrenaline, acetylcholine, glutamate, and gamma-aminobutyric acid [42,4548]. Broadly, in line with Yerkes & Dodson’s [49] arousal-performance theory, the production of these neurotransmitters, at specific exercise intensities, may help increase cognitive arousal and thus enhance cognitive performance.

Several past studies have suggested that shorter bouts of aerobic exercise may mitigate mental fatigue. Jacquet et al. [50] and Oberste et al. [51] found that completing a 15–to–30-minute bout of moderate-intensity exercise following mental fatigue induction resulted in better recovery of motor control and cognitive flexibility, respectively. Later, Ahn et al. [52] found that 20 minutes of passive (i.e., motor-driven movement) and light-intensity active exercise completed during mental fatigue induction mitigated a mental fatigue-induced inhibitory control deficit (measured via anti-saccade task).

Contrastingly, there has been some evidence suggesting that lengthy (≥40 minutes), moderate-to-high-intensity bouts of exercise may induce mental fatigue. In Moore et al.’s [53] randomized controlled trial, participants (n = 30; 15 female) completed a 40-minute memory vigilance test and perceptual discrimination test following either 60 minutes of moderate-intensity cycling, or seated rest (control). Results showed the cycling group had worse performance on both the vigilance and perceptual-discrimination tasks compared to the control group, post-intervention. Similarly, Alder et al. [54] reported that participants (n = 16) who completed a 40-minute bout of high-intensity interval training experienced a decrement in performance on a subsequent soccer-specific video anticipation assessment. Further, the decrement in performance was comparable to participants who, instead of exercise, completed a 30-minute mentally fatiguing Stroop task.

Until recently, no past investigations had examined the effect of acute aerobic exercise when completed prior to mental fatigue induction, which has important practical implications given its utility as a fatigue mitigation strategy (e.g., a student aiming to sustain attention during a lengthy lecture). Jeyarajan et al [55]. investigated the effect of a 20-minute bout of moderate-intensity exercise on subsequent inhibitory control and mental fatigue resilience. In their procedure, participants completed 20 minutes of moderate-intensity exercise, or passive cycling, or seated control, a 13-minute saccade task to evaluate inhibitory control, then finally a 20-minute Psychomotor Vigilance Task (PVT) to induce and evaluate mental fatigue. Participants demonstrated improvements to their inhibitory control in all three conditions, but no reliable improvement to their mental fatigue resilience. Furthermore, differences in inhibitory control and mental fatigue were not related to alterations in CBF. Several limitations of this work warrant further investigation: 1) mental fatigue was not induced immediately after exercise; 2) PVT was not completed at baseline (i.e., prior to exercise or saccade task); 3) PVT served as an induction and measurement of mental fatigue; and 4) exercise was not compared to an intervention that reliably mitigates mental fatigue.

Thus, the objective of this investigation was to compare the effects of three treatments on objective and subjective assessments of mental fatigue when administered immediately prior to mental fatigue induction: 1) a 20-minute, moderate-intensity bout of cycling; 2) consumption of 2.5 mg/kg caffeine; and 3) placebo. To compare these three treatments, we utilized a crossover design in which participant and experimenter were both blinded to the administration of caffeine and placebo. A 30-minute Stroop task was used for the purposes of fatigue induction. Objective mental fatigue was operationalized as participants’ performance on the psychomotor vigilance task (PVT), and subjective mental fatigue was operationalized as participants self-reported score on visual analog fatigue and energy scales. We hypothesized that 1) in the placebo condition, participants will demonstrate greater mental fatigue following a 30-minute Stroop task relative to baseline (i.e., mental fatigue induction), and 2) mental fatigue induction will be mitigated in the acute exercise and caffeine consumption conditions, to a similar degree. Fig 1 depicts a flow chart of the study design. Furthermore, Fig 2 provides a schematic of participants’ in-lab sessions.

Materials and methods

Sample power calculation

The sample size was determined a priori using the G*Power software [56]. The following parameters were used in the sample size calculation: power = 0.8, alpha = 0.05, and an effect size of ηp2 = 0.4. Rubio-Morales et al. [57] measured mental fatigue induction following a 30-minute Stroop task using a 3-minute PVT reaction time. The effect size of the post-fatigue induction increase in RT was approximately 0.594. Due to the novel acute exercise mental fatigue intervention, a more conservative effect size estimate of 0.4 was chosen. The sample size calculation yielded a target of 21 participants.

Participants

Twenty-six undergraduate and graduate students from the Western University community were recruited to participate in this study (see Table 1 for participant characteristics). The inclusion criteria were as follows: 1) aged 18–30 years, 2) consume 150–500 mg of caffeine daily, and 3) be able to read and write in English. The exclusion criteria were as follows: 1) tobacco, marijuana, or other recreational drug use, 2) prescription medication use for chronic health conditions (e.g., depression, anxiety, cardiovascular conditions, endocrine conditions), 3) diagnosed with a colour vision deficiency, 4) contraindications to exercise as identified by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+), 5) pregnancy, or breastfeeding.

Only participants who reported caffeine consumption between 150–500 mg daily were selected to target average habitual caffeine users (i.e., those who have likely experienced beneficial effects from caffeine consumption). This cutoff is in line with the average daily caffeine intake reported in university-aged populations worldwide [5860]

The upper cutoff of 500 mg/day was selected to preclude outliers with relatively high caffeine consumption who may be experiencing health risks and significant withdrawal with caffeine cessation [6163].

Prior to data collection, this study obtained ethical approval from Western University’s Health Sciences Research Ethics Board (#121715). This study also adhered to the most recent iteration of the Declaration of Helsinki, with the exception that participants were not registered in a database [64]. The recruitment and data collection for this study was conducted between May 23rd, 2023, and August 2nd, 2024, at Western University in London, Ontario, Canada.

Exercise treatment

The exercise intervention consisted of 20 minutes of active cycling at 70 rpm using a Monark 839e cycle ergometer (Monark, Vansbro, SE). The 20-minute bout consisted of a 2.5-minute warm-up, 15 minutes of cycling at a moderate intensity, and a 2.5-minute cool-down. Moderate-intensity exercise was defined as 50% of heart rate reserve (HRR; [65]). HRR target was calculated using the formula HRR = ((220 – age – HRrest) x 0.5) + HRrest [66]). HR was monitored throughout the cycling bout using a wearable heart rate monitor (Polar H10 Wearlink + Coded Transmitter, Polar Electro Inc., Lake Success, NY, USA). A researcher monitored and adjusted the resistance of the cycle ergometer to ensure the participants’ HR remained within 5% of the 50% HRR target.

Caffeine treatment

The caffeine consumption treatment consisted of participants orally ingesting a powdered caffeine solution. Each participant ingested 2.5 mg/kg (body weight) of powdered caffeine (Sigma–Aldrich Foundation, St Louis, MO) dissolved in 200 mL of water [67,68]. Participants then had 20 minutes of seated rest to permit caffeine absorption and maintain consistency with the duration of the exercise [39]. Caffeine consumption between 0.5–4 mg/kg of body mass has been shown to reliably improve alertness, vigilance, and attention [6971]. A dose of 2.5 mg/kg falls within the tested range and has been shown to produce the greatest task-induced BOLD response compared to those observed at lower or higher doses [67].

Placebo treatment

Similar to the caffeine treatment, the placebo consumption treatment consisted of participants orally ingesting a colour-matched mixture of 200 mL of water and approximately 0.67 g corn starch (i.e., a quarter teaspoon), followed by 20 minutes of seated rest [72].

Mental fatigue induction

A 30-minute Stroop task was completed following treatment to induce mental fatigue [73,74]. Several past studies have demonstrated that tasks requiring response inhibition, such as the Stroop task, are effective at inducing mental fatigue [1,7578]. Moreover, the mental fatigue induction from the Stroop task may be greater than other popular fatigue induction tasks, such as the PVT [74]. The Stroop task was completed using Inquisit software (version 4.0.8.0; Millisecond Software, 2008). The parameters of the task have been previously described by Kowal et al. [79] and Toth et al. [80]. Reaction time (RT; time in milliseconds between stimulus presentation and a participant’s response) and accuracy (proportion of correct responses) were recorded for each trial.

Measures

Demographics.

Participants were asked to report age in years, sex, education (e.g., first-year undergraduate student), hours of sleep prior to lab arrival (bedtime and wake-up time), and body weight (kg). The Godin Leisure-Time Exercise Questionnaire (GLTEQ) [81] was given to participants at their first experimental session to gauge participants’ weekly physical activity levels. As a questionnaire, the GLTEQ requires minimal technical expertise and equipment to administer. The construct validity and reliability of the GLTEQ have been supported by several past studies [8284]. Additionally, past research has suggested that GLTEQ categories may be related to cardiorespiratory fitness. Amireault & Godin [85] reported that healthy adults (n = 100) who score in the “active” category have a higher VO2 max and lower body fat percentage than those who score in the “insufficiently active or sedentary” category.

Caffeine consumption & withdrawal

The Caffeine Consumption Questionnaire-Revised (CCQ-R; [86]) was completed by participants at their first experimental session and used to estimate the amount of caffeine in milligrams that participants would consume daily. The CCQ-R provides images of caffeine-containing products (i.e., foods, beverages, and drugs) and participants are asked to “indicate how many servings per week [they] normally consume of each item”.

The Caffeine Withdrawal Symptom Questionnaire (CWSQ; [87]) was also completed by participants to assess the presence, type, and severity of caffeine withdrawal symptoms. The CWSQ consists of 23 items which focus on seven symptom clusters: 1) fatigue/drowsiness, 2) low alertness/difficulty concentrating, 3) mood disturbances, 4) low sociability/motivation to work, 5) nausea/upset stomach, 6) flu-like feelings, and 7) headache. Participants report the severity of each symptom using a 5-point, Likert-type scale ranging from 0 (not at all) to 4 (extremely). Potential scores range from 0–92; higher scores indicate a greater number of symptoms and greater symptom severity. The CWSQ was to determine if there was differences in participants’ baseline level of caffeine withdrawal, as this could potentially affect their response to the subsequent treatment.

Psychomotor Vigilance Task (PVT)

Participants completed a 5-minute psychomotor vigilance task (PVT) as an objective assessment of their mental fatigue levels. The PVT was derived from a freely available PC-PVT software (Psychomotor Vigilance Task software for PC, v. 1.1.0), which was downloaded from http://bhsai.org/downloads/pc-pvt/. The PC-PVT software was originally developed and validated by Khitrov and colleagues [88]. The 5-minute PVT protocol we utilized was adapted from Thompson et al. [89]. The test was administered using a PC (Stream 11, HP Inc., Palo Alto, CA) and an optical gaming mouse (Pavilion Gaming Mouse 300, HP Inc., Palo Alto, CA).

RT in milliseconds, false starts, and lapses were recorded for each trial. RT was identified as the primary objective mental fatigue outcome. False starts were defined as responses prior to stimulus presentation or a RT < 100 ms [90]. Basner et al. [91] demonstrated that reducing the threshold for lapses from RT > 500 ms (seen in the traditional 10-minute PVT) to RT > 355 ms supported the convergent validity of a shorter, 3-minute PVT. Accordingly, for our purposes, lapses were defined as RT > 400 ms during the 5-minute PVT.

Mental and Physical State and Trait Energy and Fatigue Scales (MPSTEFS)

Participants completed the Mental and Physical State and Trait Energy and Fatigue Scales (MPSTEFS) to provide a comprehensive assessment of state and trait fatigue and energy [92]. The 24-item MPSTEFS can be broken down into 8 sub-scales, each represented by 3 items: 1) trait mental fatigue, 2) state mental fatigue, 3) trait mental energy, 4) state mental energy, 5) trait physical fatigue, 6) state physical fatigue, 7) trait physical energy, and 8) state physical energy. On both state and trait scales, energy-related items asked about feelings of energy, vigour, and pep, whereas fatigue-related items asked about feelings of fatigue, exhaustion, and being worn out. For state sub-scale items, participants reported the intensity of their feelings in the current moment using a visual analog scale. Combining the three items on each state subscale created a potential score range from 0 (least intensity) to 300 (greatest intensity). In contrast, for trait sub-scale items, participants indicated the frequency of their feelings using a 5-point, Likert-type scale. Combining the three items on each trait subscale created a potential score range from 0 (lowest frequency) to 12 (highest frequency). The state mental fatigue subscale was identified as the primary subjective mental fatigue outcome.

Heart rate & blood pressure

HR (bpm) was assessed using a wearable (chest strap) heart rate monitor (Polar H10 Wearlink + Coded Transmitter, Polar Electro Inc., Lake Success, NY, USA). Blood pressure (mmHg) using an electronic sphygmomanometer (Omron BP7455CAN, Omron Healthcare Co., Kyoto, Japan).

Participant study characteristics are summarized in Table 1.

Procedure

Eligible participants were invited to complete three 90-minute in-lab experimental sessions. All sessions were completed between 8:00 a.m. and 1:00 p.m., each separated by at least 48 hours [93]. Moreover, participants began all three sessions at the same time of day (e.g., 9:30 a.m. Monday, Wednesday, and Friday). Participants were asked to abstain from alcohol and drugs for at least 24 hours prior to their experimental session. They were asked to abstain from caffeine and very intense physical exercise (such as running, weightlifting, circuit training, or sports) at least 12 hours prior to their experimental session. Furthermore, to control the effects of post-prandial somnolence, participants were instructed to refrain from consuming large meals at least 90 minutes prior to their experiment [94,95]. Additionally, participants were asked to adhere to their regular sleep schedule the night prior to their session and record their wake-up time and bedtime.

Upon their initial arrival at the lab, participants were asked to complete the PAR-Q+ and CCQ-R. Next, participants were given the MPSTEFS, GLTEQ, and CWSQ. Baseline HR and BP were assessed following the completion of these questionnaires.

Afterward, participants completed a baseline 5-minute PVT. Then, participants completed one of the three treatments according to their randomization: 1) aerobic exercise condition (EX), 2) caffeine consumption condition (CC), or 3) placebo consumption condition (PC). Participants were randomized to one of six Williams sequences (e.g., ABC, BCA, CAB, ACB, CBA, BAC) using permuted blocks of size 6 to achieve near-equal allocation. The randomization list was generated prior to enrollment using an online randomization tool (random.org), and assignments were concealed in sealed opaque envelopes until allocation. A single researcher (N.F.) conducted the randomization. The researcher administering the treatment (A.S.) and participants were both blinded to PC and CC treatment allocation. Following treatment, participants then completed a 30-minute Stroop task to induce mental fatigue. Finally, post-fatigue induction, participants engaged in a second 5-minute PVT. HR, BP, and subjective state mental fatigue were assessed at baseline, post-treatment (EX, CC, or PC), and post-fatigue induction. Participants were compensated with a $15 Tim Horton’s Gift Card for their participation.

Statistical analyses

The level of significance was accepted at p < 0.05 for all tests (i.e., alpha level of 0.05). PVT, questionnaire, Stroop task, and physiological data were all assessed via repeated measures ANOVA with a between-subject factor of Treatment (i.e., Exercise, Caffeine, or Placebo) and a within-subject factor of Time. All randomized participants (n = 26) were included in analyses. Prior to ANOVAs, Mauchly’s tests were conducted to assess the assumption of sphericity. Significant results from Mauchly’s test were reported, and degrees of freedom were corrected using Huynh-Feldt estimates of sphericity [96]. When significant effects were identified via repeated measure ANOVA, post-hoc Bonferroni-corrected t-tests were conducted. When conducting post-hoc tests, significant interactions took precedence over significant main effects. Moreover, pairwise comparisons were reported across either treatment or time (e.g., baseline CC compared to baseline PC or post-treatment CC, but not post-treatment PC). Effect sizes (ηp2, Cohen’s d) accompany all reported findings. Data were analyzed using JASP software (Version 0.18.3).

Physiological data and Stroop task data were analyzed as a manipulation check to gauge whether participants had physically and cognitively exerted themselves, respectively. To assess participants’ Stroop task performance over the course of mental fatigue induction, each participant’s Stroop task data was divided into the first 10%, middle 10%, and final 10% of trials completed. Given a participant who completes 1000 trials, the division would be as follows: first 10%, trials 0–100; middle 10%, trials 450–550; and final 10%, trials 900–1000. Stroop task trials were excluded if the trials were identified as outliers. Outliers were identified as being at least ± 3 standard deviations (SDs) from a participant’s condition-specific mean (e.g., a participant’s mean for incongruent trials) [97]. Outlier removal established upper and lower bounds for RT similar to lapses and false starts in the PVT, respectively. The existence of a speed-accuracy trade-off between Stroop task RT and Stroop task accuracy was evaluated via correlational analysis between accuracy and RT at each time point [98,99].

Results

Treatment equivalency check

One-way ANOVAs were conducted for CWSQ scores and hours of sleep across treatments. There were no reliable differences between treatments in baseline CWSQ (F(2, 75) = 1.077, p = 0.346, ηp2 = 0.028) and hours of sleep (F(2, 75) = 0.935, p = 0.397, ηp2 = 0.024).

Manipulation check

Stroop task RT (Fatigue induction).

Participants completed an average of 1802 trials ± 295 trials. Approximately 1.8% of these trials were identified as outliers and subsequently removed from analysis.

For control trials (i.e., coloured rectangle, rather than word, stimuli), Mauchly’s test indicated that the assumption of sphericity had been violated, χ2 (2) = 9.885, p = 0.007. The main effect of time was not significant, F(1.818, 136.337) = 1.210, p = 0.299, ηp2 = 0.016. Also, the main effect of treatment was not significant, F(2, 75) = 0.205, p = 0.815, ηp2 = 0.005. Moreover, there was no significant interaction between time and treatment F(3.636, 136.337) = 1.790, p = 0.140, ηp2 = 0.046.

For congruent trials, the main effect of time was not significant, F(2, 150) = 0.003, p = 0.997, ηp2 < 0.001. The main effect of treatment was not significant, F(2, 75) = 0.235, p = 0.792, ηp2 = 0.006. Moreover, there was no significant interaction between time and treatment, F(4, 150) = 0.350, p = 0.844, ηp2 = 0.009.

For incongruent trials, Mauchly’s test indicated that the assumption of sphericity had been violated, χ2 (2) = 37.156, p < 0.001. The main effect of time was not significant, F(1.454, 109.065) = 0.187, p = 0.759, ηp2 = 0.002. The main effect of treatment was not significant, F(2, 75) = 0.091, p = 0.913, ηp2 = 0.002. Moreover, there was a non-significant interaction between time and treatment, F(2.908, 109.065) = 0.265, p = 0.844, ηp2 = 0.007. Fig 3 depicts incongruent trial RT means and confidence intervals (CIs) across treatments.

thumbnail
Fig 3. Incongruent Stroop trial RT.

Values represent means. Error bars represent 95% CI.

https://doi.org/10.1371/journal.pone.0348279.g003

Stroop task accuracy (fatigue induction)

For control trials, the main effect of time was significant, F(2, 150) = 16.749, p < 0.001, ηp2 = 0.183. However, the main effect of treatment was not significant, F(2, 75) = 0.010, p = 0.990, ηp2 < 0.001. Also, there was no significant interaction between time and treatment, F(4, 150) = 0.877, p = 0.479, ηp2 = 0.023. Pairwise comparisons using a Bonferroni correction revealed a significant decrease in accuracy between first and middle (t(25) = 4.301, p < 0.001, d = 0.523), and first and final time points (t(25) = 5.504, p < 0.001, d = 0.669). However, there was no difference between the middle and final time points (t(25) = 1.204, p = 0.692, d = 0.146).

For congruent trials, the main effect of time was significant, F(2, 150) = 13.182, p < 0.001, ηp2 = 0.149. However, the main effect of treatment was not significant, F(2, 75) = 0.064, p = 0.938, ηp2 = 0.002. Also, there was no significant interaction between time and treatment, F(4, 150) = 0.450, p = 0.772, ηp2 = 0.012. Pairwise comparisons using a Bonferroni correction revealed a significant decrease in accuracy between first and middle (t(25) = 4.466, p < 0.001, d = 0.603), and first and final time points (t(25) = 4.428, p < 0.001, d = 0.598). However, there was no difference between the middle and final time points (t(25) = −0.038, p = 1.000, d = −0.005).

For incongruent trials, the main effect of time was significant, F(2, 150) = 14.670, p < 0.001, ηp2 = 0.164. However, the main effect of treatment was not significant, F(2, 75) = 0.095, p = 0.909, ηp2 = 0.003. Also, there was no significant interaction between time and treatment, F(4, 150) = 0.427, p = 0.789, ηp2 = 0.011. Pairwise comparisons using a Bonferroni correction revealed a significant decrease in accuracy between first and middle (t(25) = 3.145, p < 0.006, d = 0.331), first and final (t(25) = 5.392, p < 0.001, d = 0.568). However, there was no reliable difference between the middle and final time points (t(25) = 2.247, p = 0.078, d = 0.237). Correlational analyses between RT and accuracy revealed non-significant interactions at all time points (all p’s > 0.05). Fig 4 depicts incongruent trial accuracy means and CIs across treatments.

thumbnail
Fig 4. Incongruent Stroop trial accuracy.

Values represent means. Error bars represent 95% CI.

https://doi.org/10.1371/journal.pone.0348279.g004

Physiological results

Data on HR, SBP, and DBP can be found in the supporting information (S1 File).

PVT (objectively measured fatigue)

RT (primary outcome).

The main effect of time was not significant, F(1, 75) = 0.744 p = 0.391, ηp2 = 0.010. The main effect of treatment was not significant, F(2, 75) = 2.297, p = 0.108, ηp2 = 0.058. However, there was a significant interaction between time and treatment, F(2, 75) = 3.802, p = 0.027, ηp2 = 0.092. Pairwise comparisons for time and treatment interactions using a Bonferroni correction were non-significant between all treatment time points (all p’s > 0.05). Fig 5 depicts PVT RT means and CIs across treatments.

thumbnail
Fig 5. PVT RT.

Values represent means. Error bars represent 95% CI.

https://doi.org/10.1371/journal.pone.0348279.g005

Lapses & false starts (Primary Outcome)

Data on PVT Lapses and False Starts can be found in the supporting information (S1 File).

Self-reported mental and physical state (subjectively measured fatigue)

Mental fatigue (primary outcome).

Mauchly’s test indicated that the assumption of sphericity had been violated, χ2 (2) = 17.403, p < 0.001. The main effect of time was significant, F(1.686, 126.453) = 23.723, p < 0.001, ηp2 = 0.240. The main effect of treatment was not significant, F(2, 75) = 1.148, p = 0.323, ηp2 = 0.030. Moreover, there was a non-significant interaction between time and treatment, F(3.372, 126.453) = 2.378, p = 0.066, ηp2 = 0.060. Pairwise comparisons by time using a Bonferroni correction revealed an increase in scores from post-treatment to post-fatigue induction t(25) = −6.781, p < 0.001, d = −0.735) and from baseline to post-fatigue induction (t(25) = −4.437, p < 0.001, d = −0.481). However, there was no significant difference between baseline and post-treatment t(25) = 2.345, p = 0.061, d = 0.254). Fig 6 depicts state mental fatigue means and CIs across treatments.

thumbnail
Fig 6. State Mental Fatigue Scores.

Values represent means. Error bars represent 95% CI.

https://doi.org/10.1371/journal.pone.0348279.g006

To facilitate comparison with the objective primary outcome, state mental fatigue was also analyzed without the post-treatment time point. The main effect of time was significant, F(1, 75) = 16.196, p < 0.001, ηp2 = 0.178. The main effect of treatment was not significant, F(2, 75) = 1.095, p = 0.340, ηp2 = 0.028. Moreover, there was a significant interaction between time and treatment, F(2, 75) = 3.129, p = 0.050, ηp2 = 0.077. Pairwise comparisons using a Bonferroni correction revealed a significant increase in mental fatigue from baseline EX to post-fatigue induction EX (t(25) = −4.115, p = 0.001, d = −0.843). Fig 7 depicts state mental fatigue means and CIs across treatments without post-treatment data.

thumbnail
Fig 7. State Mental Fatigue Scores–Post-treatment Data Removed.

Values represent means. Error bars represent 95% CI.

https://doi.org/10.1371/journal.pone.0348279.g007

Other fatigue & energy outcomes

Data on mental energy, physical fatigue, and physical energy can be found in the supporting information (S1 File).

Discussion

The present investigation sought to compare the effects of three treatments on subjective and objective assessments of mental fatigue when administered prior to mental fatigue induction: 1) a 20-minute, moderate-intensity bout of cycling; 2) consumption of 2.5 mg/kg caffeine; and 3) placebo. To begin, we will discuss the Stroop task fatigue induction, followed by HR and BP, and then the objective and subjective fatigue outcomes.

Mental fatigue induction (Stroop task)

The results indicated that participants’ RTs did not reliably lengthen as a function of time in the Stroop task. Since RT was resilient to “Time on Task” effects, a decrement in accuracy over time can be anticipated [98].

Accuracy significantly decreased over time across all three Stroop trial conditions, irrespective of treatment. This suggests that participants were indeed cognitively exerting themselves during the Stroop task [77]. Although these results suggest successful mental fatigue induction, they should be interpreted with caution. Mangin et al. [100] found declines in performance during a 30-minute Stroop task were correlated with subjective measures of boredom (r = −0.332, p = 0.003). Several past studies have suggested that when in a mentally fatigued state, cognitive compensatory mechanisms reallocate attentional resources to preserve either RT or accuracy; hence, a speed-accuracy trade-off is commonly observed in incongruent Stroop trials [98,100102]. However, our correlational analyses did not demonstrate a significant speed-accuracy trade-off.

In summary, Stroop task results reflect that participants exerted cognitive effort throughout the 30-minute induction. The primary outcomes must be reviewed to determine whether mental fatigue was effectively induced.

Physiological measures

Full discussion of physiological measures can be found in the supporting information (S1 File). In summary, physiological variables increased as anticipated in the exercise and caffeine consumption conditions and remained relatively stable in the placebo consumption condition.

PVT RT (primary objective outcome)

PVT RT results indicated a significant time-by-treatment interaction effect with a medium effect size (ηp2 = 0.092; [103]). Thus, a 30-minute Stroop task did result in a significant difference in objective mental fatigue measured via 5-minute PVT performance. However, no significant differences were found in post-hoc Bonferroni-corrected pairwise comparisons. This contradicts the hypothesis that the Stroop task would result in differences in PVT RT between treatments from baseline to post-fatigue induction. Furthermore, this is in line with the findings of Jeyarajan et al. [55] which suggest that a 20-minute bout of moderate-intensity exercise imparts no reliable benefit to mental fatigue resilience measured via PVT Differences in PVT duration may partially account for the divergence in PVT findings. Roach et al.’s [104] comparison of 3-minute, 5-minute, and 10-minute PVT formats suggested that the 5-minute format was more sensitive to the effects of fatigue.

State mental fatigue (primary subjective outcome)

As anticipated, participants reported significantly greater subjective mental fatigue from post-treatment to post-fatigue induction (d = −0.735, medium effect size; [105]). This suggests that the 30-minute Stroop task successfully induced subjective mental fatigue. Mechanistically, this may be due to the accrual of neurometabolites (e.g., adenosine, glutamate) during task completion, leading to greater feelings of effort [106,107]. Placebo consumption, caffeine consumption, and exercise treatments did not demonstrate a differential impact on mental fatigue status (i.e., no significant time by treatment interaction), contradicting our hypothesis. However, it should be acknowledged that after removing the post-treatment time point, the time by treatment interaction effect was significant (ηp2 = 0.077, medium effect size; [103]), and pairwise comparisons using a Bonferroni correction revealed a significant increase in mental fatigue from baseline exercise to post-fatigue induction exercise (d = −0.843, large effect size, [105]). Thus, exercise may have failed to mitigate subjective mental fatigue.

Comparing objective and subjective primary outcomes

In both subjective and objective primary outcomes, exercise did not appear to mitigate mental fatigue. The effect of exercise on cognition is modulated by exercise intensity, duration, and participants’ fitness [35]. The present investigation chose a 20-minute bout of moderate-intensity exercise since this has been shown to robustly improve cognitive function (esp. executive function). However, this may not necessarily reflect the optimal dosage of exercise to support mental fatigue resilience. Participants’ fitness status may also exert a differential impact on exercise’s relationship with mental fatigue than on cognitive function. Furthermore, the present study is unable to conclude if the exercise treatment achieved relevant changes in CBF or neurometabolite concentrations, as these variables were not assessed. Differences in participants’ mental fatigue were found in our subjective outcome, but not in our objective outcome. Subjective feelings of mental fatigue have previously been suggested to precede objective performance decrements [108110]. Among the earliest to suggest this temporal lag was Thorndike [111]. In his seminal mental fatigue investigation, he noted, “We can feel mentally fatigued without being so, so that the feelings serve as a sign to stop working long before our actual ability to work has suffered any important decrease”. Accordingly, a longer duration of mental fatigue induction may be required to elicit objectively measurable mental fatigue than subjectively measurable mental fatigue. This may, in part, explain the differences in the present investigations’ subjective and objective outcomes.

In both subjective and objective outcomes, caffeine and placebo did not exhibit a reliable difference in pairwise comparisons. This may be due to several factors. It may be because both treatments are mitigating mental fatigue to a similar degree (i.e., placebo effect). Conversely, caffeine has a distinct bitter flavour which may not have been replicated adequately by corn starch. This may have contributed to unblinding between the conditions. The dosage of caffeine may have been inappropriate to produce a significant difference in mental fatigue resilience. Alternatively, the severity of the mental fatigue induction may have been insufficient to produce reliable post-hoc differences from the caffeine and placebo treatments.

Other fatigue and energy outcomes

As anticipated, participants reported significantly less subjective mental energy from post-treatment to post-fatigue induction, and baseline to post-fatigue induction. This further supports participants having mentally exerted themselves during the 30-minute Stroop task. Loy et al.’s [112] meta-analysis reported that a 21–40-minute bout of light-to-moderate intensity exercise decreased self-reported fatigue, only when energy levels were concurrently increased. This may also explain, in part, why the exercise treatment was ineffective: feelings of mental energy were not significantly increased, an effect which Loy et al. [112] suggest may be modulated by the intensity and duration of the exercise bout.

Participants reported significantly greater physical fatigue and lesser mental energy from baseline to post-fatigue induction, and post-treatment to post-fatigue induction. These findings supplement an existing body of evidence that suggests mental and physical fatigue may share a common process (i.e., central fatigue) [53,113117].

In summary, mental energy and physical fatigue & energy scores are in agreement with state mental fatigue and physiological data. These results altogether support that the 30-minute Stroop task induced subjective mental fatigue, and the 20-minute moderate-intensity cycling treatment posed the anticipated physical demands.

Limitations, implications, future directions

The present investigation had several limitations. In recognition of the transience of post-exercise effects, 5-minute PVT performance was not measured post-treatment (i.e., participants progressed to the fatigue induction immediately following the MPSTEFS). Future investigations should aim to objectively assess mental fatigue status both immediately post-treatment and following mental fatigue induction. The 3-minute PVT may be an effective tool for these purposes, minimizing the time lag between post-treatment and fatigue induction. There were no EEG or HRV measures included in the present study. Future research should utilize these tools to gather insight into participants’ mental fatigue status during fatigue induction and PVT assessment. Also, a 30-minute Stroop task was utilized for fatigue induction. Future studies should compare various tasks and durations to find the optimal way to induce mental fatigue. Further, recent work by Hassan et al. [118] demonstrated that employing a cognitive task battery may be a promising method to induce mental fatigue. As a pragmatic control measure, we advised participants to avoid “large meals” within 90 minutes of testing; however, future work should impose stricter nutritional control to reduce the influence of post-prandial states. Moreover, powdered caffeine may have had a bitter taste which influenced participants’ reactions to their treatment. Future studies should attempt to find an alternative taste-matched placebo treatment to reduce any expectancy effects. Furthermore, the present study specifically examined the efficacy of a 20-minute bout of moderate-intensity aerobic exercise. Future investigations should explore various durations and intensities of exercise to find the optimal dose to mitigate mental fatigue. Participants’ self-reported behaviour was relied upon for caffeine abstinence and hours of sleep. Future investigations may benefit from confirming caffeine abstinence empirically and obtaining a more thorough assessment of sleep quality and volume; this may be achieved by collecting and processing a saliva sample from participants upon lab arrival and having participants complete a validated sleep assessment, such as the Pittsburgh Sleep Quality Index [119], respectively. Participants were not compared based on their daily caffeine consumption. Future studies should compare the effects of caffeine on mental fatigue in those with varying degrees of daily caffeine consumption, including those who are caffeine naïve. The participants in the present study were primarily young, active, and highly educated. Future research should examine the effects of caffeine and acute exercise on mental fatigue across various age groups, physical activity levels, and education levels. Lastly, the present study evaluated the individual effects of aerobic exercise and caffeine consumption on mental fatigue; future studies should investigate the effects of combining these interventions on mental fatigue.

At present, it appears that a 20-minute bout of moderate-intensity exercise, completed before mental fatigue induction, does not aid in mitigating mental fatigue accrual. Further investigations are warranted to explore the potential of varying exercise intensities and durations in mitigating mental fatigue and identify non-harmful alternatives to caffeine consumption. Creatine monohydrate supplementation has shown promise in mitigating mental fatigue [120]. The effects of combining interventions such as creatine monohydrate supplementation and acute exercise should be evaluated in future research. Such investigations not only serve to elucidate the efficacy of aerobic exercise and other caffeine alternatives in mitigating mental fatigue but ultimately provide guidance for health-related interventions for the general population.

Conclusion

Findings from the present study suggest that a 30-minute Stroop task is effective in inducing subjective mental fatigue, but not objective mental fatigue. Consumption of 2.5 mg/kg of caffeine may mitigate subjective mental fatigue similar to placebo consumption in adult caffeine consumers. Furthermore, a 20-minute bout of moderate-intensity aerobic exercise may not be an effective method of mitigating fatigue. Further investigations are warranted to explore the potential of varying exercise intensities and durations in mitigating mental fatigue. Moreover, future research into the mechanisms underlying mental fatigue may aid in the development of more efficacious mental fatigue interventions.

Supporting information

Acknowledgments

The authors would like to acknowledge Dr. Erind Alushaj for helping guide the statistical analysis process.

References

  1. 1. Ishii A, Tanaka M, Watanabe Y. Neural mechanisms of mental fatigue. Rev Neurosci. 2014;25(4):469–79. pmid:24926625
  2. 2. Phillips RO. A review of definitions of fatigue – And a step towards a whole definition. Transportation Research Part F: Traffic Psychology and Behaviour. 2015;29:48–56.
  3. 3. Akerstedt T, Knutsson A, Westerholm P, Theorell T, Alfredsson L, Kecklund G. Mental fatigue, work and sleep. J Psychosom Res. 2004;57(5):427–33. pmid:15581645
  4. 4. Borghini G, Astolfi L, Vecchiato G, Mattia D, Babiloni F. Measuring neurophysiological signals in aircraft pilots and car drivers for the assessment of mental workload, fatigue and drowsiness. Neurosci Biobehav Rev. 2014;44:58–75. pmid:23116991
  5. 5. Kaur J, Malik M, Sharma P, Jangra S. Effect of mental fatigue on memory and retention: An experimental study. Journal of Emerging Technologies and Innovative Research. 2018;5:620–5.
  6. 6. Lorist MM. Impact of top-down control during mental fatigue. Brain Res. 2008;1232:113–23. pmid:18687317
  7. 7. van der Linden D. The urge to stop: The cognitive and biological nature of acute mental fatigue. Cognitive fatigue: Multidisciplinary perspectives on current research and future applications. Washington, DC, US: American Psychological Association. 2011. p. 149–64.
  8. 8. van der Linden D, Eling P. Mental fatigue disturbs local processing more than global processing. Psychol Res. 2006;70(5):395–402. pmid:15968553
  9. 9. Filippi M, Krähenmann R, Fissler P. The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue. Front Psychol. 2022;13:920556. pmid:35800955
  10. 10. Gibson ASC, Baden DA, Lambert MI, Lambert EV, Harley YXR, Hampson D. The Conscious Perception of the Sensation of Fatigue. Sports Med. 2003;33:167–76.
  11. 11. Smith TW, Marsden P, Hout M, Kim J. General social surveys, 1972-2014. The Roper Center for Public Opinion Research, University of Connecticut. 2015.
  12. 12. Ricci JA, Chee E, Lorandeau AL, Berger J. Fatigue in the U.S. workforce: prevalence and implications for lost productive work time. J Occup Environ Med. 2007;49(1):1–10. pmid:17215708
  13. 13. Morrison RE, Keating HJ. Fatigue in primary care. Obstetrics and Gynecology Clinics of North America. 2001;28:225–40.
  14. 14. Lorist MM, Tops M. Caffeine, fatigue, and cognition. Brain Cogn. 2003;53(1):82–94. pmid:14572506
  15. 15. Lorist MM, Boksem MAS, Ridderinkhof KR. Impaired cognitive control and reduced cingulate activity during mental fatigue. Brain Res Cogn Brain Res. 2005;24(2):199–205. pmid:15993758
  16. 16. van Duinen H, Lorist MM, Zijdewind I. The effect of caffeine on cognitive task performance and motor fatigue. Psychopharmacology (Berl). 2005;180(3):539–47. pmid:15723227
  17. 17. Kumar N, Wheaton LA, Snow TK, Millard-Stafford M. Exercise and caffeine improve sustained attention following fatigue independent of fitness status. Fatigue: Biomedicine, Health & Behavior. 2015;3(2):104–21.
  18. 18. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83–133. pmid:10049999
  19. 19. Fulgoni VL 3rd, Keast DR, Lieberman HR. Trends in intake and sources of caffeine in the diets of US adults: 2001-2010. Am J Clin Nutr. 2015;101(5):1081–7. pmid:25832334
  20. 20. Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014;63:136–42. pmid:24189158
  21. 21. Ruxton CHS. The impact of caffeine on mood, cognitive function, performance and hydration: a review of benefits and risks. Nutrition Bulletin. 2008;33(1):15–25.
  22. 22. Brice CF, Smith AP. Effects of caffeine on mood and performance: a study of realistic consumption. Psychopharmacology (Berl). 2002;164(2):188–92. pmid:12404081
  23. 23. Smit HJ, Rogers PJ. Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology (Berl). 2000;152(2):167–73. pmid:11057520
  24. 24. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002;40(9):1243–55. pmid:12204388
  25. 25. Koller W, Cone S, Herbster G. Caffeine and tremor. Neurology. 1987;37(1):169–72. pmid:3796831
  26. 26. Ruiz-Moreno C, Lara B, Salinero JJ, Brito de Souza D, Ordovás JM, Del Coso J. Time course of tolerance to adverse effects associated with the ingestion of a moderate dose of caffeine. Eur J Nutr. 2020;59(7):3293–302. pmid:31900579
  27. 27. Sawyer DA, Julia HL, Turin AC. Caffeine and human behavior: arousal, anxiety, and performance effects. J Behav Med. 1982;5(4):415–39. pmid:7154064
  28. 28. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004;176(1):1–29. pmid:15448977
  29. 29. Rogers PJ, Heatherley SV, Mullings EL, Smith JE. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance. Psychopharmacology (Berl). 2013;226(2):229–40. pmid:23108937
  30. 30. Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci. 2007;61(3):263–8. pmid:17472594
  31. 31. McGregor TJ, Batis JC. A Novel Method for Assessing Caffeine Dependence. Journal of Caffeine Research. 2016;6(1):26–33.
  32. 32. Striley CLW, Griffiths RR, Cottler LB. Evaluating Dependence Criteria for Caffeine. J Caffeine Res. 2011;1(4):219–25. pmid:24761264
  33. 33. Ferré S. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology (Berl). 2016;233(10):1963–79. pmid:26786412
  34. 34. Striley MCW, Hughes PJR, Griffiths R, Juliano L, Budney AJ. A Critical Examination of the Caffeine Provisions in the Diagnostic and Statistical Manual, 5th Edition (DSM-5). Journal of Caffeine Research. 2013;3(3):101–7.
  35. 35. Chang YK, Labban JD, Gapin JI, Etnier JL. The effects of acute exercise on cognitive performance: a meta-analysis. Brain Res. 2012;1453:87–101. pmid:22480735
  36. 36. Ludyga S, Gerber M, Brand S, Holsboer-Trachsler E, Pühse U. Acute effects of moderate aerobic exercise on specific aspects of executive function in different age and fitness groups: A meta-analysis. Psychophysiology. 2016;53(11):1611–26. pmid:27556572
  37. 37. Pontifex MB, McGowan AL, Chandler MC, Gwizdala KL, Parks AC, Fenn K, et al. A primer on investigating the after effects of acute bouts of physical activity on cognition. Psychology of Sport and Exercise. 2019;40:1–22.
  38. 38. Tomporowski PD. Effects of acute bouts of exercise on cognition. Acta Psychol (Amst). 2003;112(3):297–324. pmid:12595152
  39. 39. Morava A, Fagan MJ, Prapavessis H. Effects of caffeine and acute aerobic exercise on working memory and caffeine withdrawal. Sci Rep. 2019;9:19644.
  40. 40. Liu J, Min L, Liu R, Zhang X, Wu M, Di Q, et al. The effect of exercise on cerebral blood flow and executive function among young adults: a double-blinded randomized controlled trial. Sci Rep. 2023;13(1):8269. pmid:37217511
  41. 41. McGregor K, Sweatt S. Increased Modulation of GABA Receptors After Aerobic Exercise Intervention in Aging Adults. Archives of Physical Medicine and Rehabilitation. 2025;106(4):e148–9.
  42. 42. Maddock RJ, Casazza GA, Fernandez DH, Maddock MI. Acute Modulation of Cortical Glutamate and GABA Content by Physical Activity. J Neurosci. 2016;36(8):2449–57. pmid:26911692
  43. 43. Phillips AA, Chan FH, Zheng MMZ, Krassioukov AV, Ainslie PN. Neurovascular coupling in humans: Physiology, methodological advances and clinical implications. J Cereb Blood Flow Metab. 2016;36(4):647–64. pmid:26661243
  44. 44. Smith KJ, Ainslie PN. Regulation of cerebral blood flow and metabolism during exercise. Exp Physiol. 2017;102(11):1356–71. pmid:28786150
  45. 45. Kurosawa M, Okada K, Sato A, Uchida S. Extracellular release of acetylcholine, noradrenaline and serotonin increases in the cerebral cortex during walking in conscious rats. Neurosci Lett. 1993;161(1):73–6. pmid:8255551
  46. 46. McMorris T. The acute exercise-cognition interaction: From the catecholamines hypothesis to an interoception model. Int J Psychophysiol. 2021;170:75–88. pmid:34666105
  47. 47. McMorris T, Davranche K, Jones G, Hall B, Corbett J, Minter C. Acute incremental exercise, performance of a central executive task, and sympathoadrenal system and hypothalamic-pituitary-adrenal axis activity. Int J Psychophysiol. 2009;73(3):334–40. pmid:19454298
  48. 48. Zouhal H, Jacob C, Delamarche P, Gratas-Delamarche A. Catecholamines and the effects of exercise, training and gender. Sports Med. 2008;38(5):401–23. pmid:18416594
  49. 49. Yerkes RM, Dodson JD. The relation of strength of stimulus to rapidity of habit-formation. 1908.
  50. 50. Jacquet T, Poulin-Charronnat B, Bard P, Perra J, Lepers R. Physical Activity and Music to Counteract Mental Fatigue. Neuroscience. 2021;478:75–88. pmid:34601062
  51. 51. Oberste M, de Waal P, Joisten N, Walzik D, Egbringhoff M, Javelle F, et al. Acute aerobic exercise to recover from mental exhaustion - a randomized controlled trial. Physiol Behav. 2021;241:113588. pmid:34516957
  52. 52. Ahn J, Tari B, Morava A, Prapavessis H, Heath M. A single bout of passive exercise mitigates a mental fatigue-induced inhibitory control deficit. Exp Brain Res. 2023;241(7):1835–45. pmid:37256338
  53. 53. Moore RD, Romine MW, O’connor PJ, Tomporowski PD. The influence of exercise-induced fatigue on cognitive function. J Sports Sci. 2012;30(9):841–50. pmid:22494399
  54. 54. Alder D, Broadbent DP, Poolton J. The combination of physical and mental load exacerbates the negative effect of each on the capability of skilled soccer players to anticipate action. J Sports Sci. 2021;39(9):1030–8. pmid:33274696
  55. 55. Jeyarajan G, Ayaz A, Herold F, Zou L, Heath M. A single bout of aerobic exercise does not alter inhibitory control preparatory set cerebral hemodynamics: Evidence from the antisaccade task. Brain Cogn. 2024;179:106182. pmid:38824809
  56. 56. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91. pmid:17695343
  57. 57. Rubio-Morales A, Díaz-García J, Barbosa C, Habay J, López-Gajardo MÁ, García-Calvo T. Do Cognitive, Physical, and Combined Tasks Induce Similar Levels of Mental Fatigue? Testing the Effects of Different Moderating Variables. Motor Control. 2022;26(4):630–48. pmid:35905976
  58. 58. El-Nimr N, Bassiouny S, Tayel D. Pattern of Caffeine Consumption Among University Students. Journal of High Institute of Public Health. 2019;0(0):153–60.
  59. 59. Lee BH, Park YS, Kim JS, Yoo JH, Lee JK. Caffeine consumption and its related symptoms in university students. Korean J Fam Med. 2007;28:9–16.
  60. 60. Martyn D, Lau A, Richardson P, Roberts A. Temporal patterns of caffeine intake in the United States. Food Chem Toxicol. 2018;111:71–83. pmid:29109041
  61. 61. Booth N, Saxton J, Rodda SN. Estimates of Caffeine Use Disorder, Caffeine Withdrawal, Harm and Help-seeking in New Zealand: A cross-sectional survey. Addict Behav. 2020;109:106470. pmid:32485545
  62. 62. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the Safety of Caffeine. EFSA Journal. 2015;13:4102.
  63. 63. Verster JC, Koenig J. Caffeine intake and its sources: A review of national representative studies. Crit Rev Food Sci Nutr. 2018;58(8):1250–9. pmid:28605236
  64. 64. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.
  65. 65. ACSM. ACSM’s guidelines for exercise testing and prescription. Lippincott Williams & Wilkins. 2013.
  66. 66. KARVONEN MJ, KENTALA E, MUSTALA O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307–15. pmid:13470504
  67. 67. Chen Y, Parrish TB. Caffeine dose effect on activation-induced BOLD and CBF responses. Neuroimage. 2009;46(3):577–83. pmid:19289172
  68. 68. Haldi J, Bachmann G, Ensor C, Wynn W. The Effects on Respiratory Metabolism Produced by Equal Amounts of Caffeine in the Form of Coffee, Tea and the Pure Alkaloid. The Journal of Nutrition. 1944;27(4):287–93.
  69. 69. Hasenfratz M, Bättig K. Acute dose-effect relationships of caffeine and mental performance, EEG, cardiovascular and subjective parameters. Psychopharmacology (Berl). 1994;114(2):281–7. pmid:7838921
  70. 70. McLellan TM, Caldwell JA, Lieberman HR. A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev. 2016;71:294–312. pmid:27612937
  71. 71. Waer FB, Laatar R, Jouira G, Srihi S, Rebai H, Sahli S. Functional and cognitive responses to caffeine intake in middle-aged women are dose depending. Behav Brain Res. 2021;397:112956. pmid:33035593
  72. 72. Abbassi F, Müller SA, Steffen T, Schmied BM, Warschkow R, Beutner U, et al. Coffee is more than just caffeine – a single-center, randomized, double-blinded, placebo-controlled superiority trial (CaCo trial). British Journal of Surgery. 2022;109(Supplement_3).
  73. 73. Junior AF, Chierotti P, Gabardo JM, Giovanini B, Okano AH, Buzzachera CF. Residual effects of mental fatigue on subjective fatigue, reaction time and cardiac responses. Rev Psicol Deporte. 2020;29:27–34.
  74. 74. Smith MR, Chai R, Nguyen HT, Marcora SM, Coutts AJ. Comparing the Effects of Three Cognitive Tasks on Indicators of Mental Fatigue. J Psychol. 2019;153(8):759–83. pmid:31188721
  75. 75. Lorist MM, Faber LG. Consideration of the influence of mental fatigue on controlled and automatic cognitive processes and related neuromodulatory effects. Cognitive fatigue: Multidisciplinary perspectives on current research and future applications. Washington, DC, US: American Psychological Association. 2011. p. 105–26.
  76. 76. Marcora SM, Staiano W, Manning V. Mental fatigue impairs physical performance in humans. J Appl Physiol (1985). 2009;106(3):857–64. pmid:19131473
  77. 77. Rauch W, Schmitt K. Fatigue of cognitive control in the stroop-task. In: Proceedings of the annual meeting of the cognitive science society. 2009. https://escholarship.org/content/qt6kk7h88b/qt6kk7h88b.pdf
  78. 78. Shou G, Ding L. Ongoing EEG oscillatory dynamics suggesting evolution of mental fatigue in a color-word matching stroop task. In: 2013 6th International IEEE/EMBS Conference on Neural Engineering (NER), 2013. 1339–42.
  79. 79. Kowal M, Toth AJ, Exton C, Campbell MJ. Different cognitive abilities displayed by action video gamers and non-gamers. Computers in Human Behavior. 2018;88:255–62.
  80. 80. Toth AJ, Kowal M, Campbell MJ. The Color-Word Stroop Task Does Not Differentiate Cognitive Inhibition Ability Among Esports Gamers of Varying Expertise. Front Psychol. 2019;10:2852. pmid:31920879
  81. 81. Godin G. The Godin-Shephard leisure-time physical activity questionnaire. Health & Fitness Journal of Canada. 2011;4:18–22.
  82. 82. Amireault S, Godin G. Validation of using fitness center attendance electronic records to assess the frequency of moderate/vigorous leisure-time physical activity among adults. Measurement in Physical Education and Exercise Science. 2014;18:13–30.
  83. 83. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–6. pmid:4053261
  84. 84. Lamb KL, Brodie DA. Leisure-time physical activity as an estimate of physical fitness: a validation study. J Clin Epidemiol. 1991;44(1):41–52. pmid:1986056
  85. 85. Amireault S, Godin G. The Godin-Shephard leisure-time physical activity questionnaire: validity evidence supporting its use for classifying healthy adults into active and insufficiently active categories. Percept Mot Skills. 2015;120(2):604–22. pmid:25799030
  86. 86. Irons JG, Bassett DT, Prendergast CO, Landrum RE, Heinz AJ. Development and Initial Validation of the Caffeine Consumption Questionnaire-Revised. Journal of Caffeine Research. 2016;6(1):20–5.
  87. 87. Juliano LM, Huntley ED, Harrell PT, Westerman AT. Development of the caffeine withdrawal symptom questionnaire: caffeine withdrawal symptoms cluster into 7 factors. Drug Alcohol Depend. 2012;124(3):229–34. pmid:22341956
  88. 88. Khitrov MY, Laxminarayan S, Thorsley D, Ramakrishnan S, Rajaraman S, Wesensten NJ, et al. PC-PVT: a platform for psychomotor vigilance task testing, analysis, and prediction. Behav Res Methods. 2014;46(1):140–7. pmid:23709163
  89. 89. Thompson BJ, Shugart C, Dennison K, Louder TJ. Test-retest reliability of the 5-minute psychomotor vigilance task in working-aged females. J Neurosci Methods. 2022;365:109379. pmid:34627928
  90. 90. Basner M, Dinges DF. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep. 2011;34(5):581–91. pmid:21532951
  91. 91. Basner M, Dinges DF. An adaptive-duration version of the PVT accurately tracks changes in psychomotor vigilance induced by sleep restriction. Sleep. 2012;35(2):193–202. pmid:22294809
  92. 92. O’Connor PJ. Evaluation of four highly cited energy and fatigue mood measures. J Psychosom Res. 2004;57(5):435–41. pmid:15581646
  93. 93. Gardiner CL, Weakley J, Burke LM, Fernandez F, Johnston RD, Leota J, et al. Dose and timing effects of caffeine on subsequent sleep: a randomized clinical crossover trial. Sleep. 2025;48(4):zsae230. pmid:39377163
  94. 94. Sakai N, Yamamoto K, Kawabata H. Comparison of the effects of high-carbohydrate and low-carbohydrate meals on drowsiness and biological indices. FSTR. 2023;29(6):521–32.
  95. 95. Fewkes JJ, Kellow NJ, Cowan SF, Williamson G, Dordevic AL. A single, high-fat meal adversely affects postprandial endothelial function: a systematic review and meta-analysis. Am J Clin Nutr. 2022;116(3):699–729. pmid:35665799
  96. 96. Huynh H, Feldt LS. Estimation of the Box Correction for Degrees of Freedom from Sample Data in Randomized Block and Split-Plot Designs. Journal of Educational Statistics. 1976;1(1):69.
  97. 97. Osborne JW, Overbay A. The power of outliers (and why researchers should always check for them). Practical Assessment, Research, and Evaluation. 2019;9:6.
  98. 98. Rozand V, Lebon F, Papaxanthis C, Lepers R. Effect of mental fatigue on speed-accuracy trade-off. Neuroscience. 2015;297:219–30. pmid:25849613
  99. 99. Vandierendonck A. On the Utility of Integrated Speed-Accuracy Measures when Speed-Accuracy Trade-off is Present. J Cogn. 2021;4(1):22. pmid:33778368
  100. 100. Mangin T, Audiffren M, Lorcery A, Mirabelli F, Benraiss A, André N. A plausible link between the time-on-task effect and the sequential task effect. Front Psychol. 2022;13:998393. pmid:36389536
  101. 101. Boksem MAS, Meijman TF, Lorist MM. Effects of mental fatigue on attention: an ERP study. Brain Res Cogn Brain Res. 2005;25(1):107–16. pmid:15913965
  102. 102. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychol Rev. 2001;108(3):624–52. pmid:11488380
  103. 103. Richardson JTE. Eta squared and partial eta squared as measures of effect size in educational research. Educational Research Review. 2011;6(2):135–47.
  104. 104. Roach GD, Dawson D, Lamond N. Can a shorter psychomotor vigilance task be used as a reasonable substitute for the ten‐minute psychomotor vigilance task?. Chronobiology International. 2006;23:1379–87.
  105. 105. Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863. pmid:24324449
  106. 106. McMorris T. Cognitive fatigue effects on physical performance: The role of interoception. Sports Med. 2020;50:1703–8.
  107. 107. Wiehler A, Branzoli F, Adanyeguh I, Mochel F, Pessiglione M. A neuro-metabolic account of why daylong cognitive work alters the control of economic decisions. Curr Biol. 2022;32(16):3564-3575.e5. pmid:35961314
  108. 108. Dinges DF, Pack F, Williams K, Gillen KA, Powell JW, Ott GE, et al. Cumulative Sleepiness, Mood Disturbance, and Psychomotor Vigilance Performance Decrements During a Week of Sleep Restricted to 4–5 Hours per Night. Sleep. 1997;20: 267–77.
  109. 109. Kanfer R. Determinants and consequences of subjective cognitive fatigue. Cognitive fatigue: Multidisciplinary perspectives on current research and future applications. Washington, DC, US: American Psychological Association. 2011. p. 189–207.
  110. 110. Kurzban R, Duckworth A, Kable JW, Myers J. An opportunity cost model of subjective effort and task performance. Behav Brain Sci. 2013;36(6):661–79. pmid:24304775
  111. 111. Thorndike E. Mental fatigue. Psychological Review. 1900;7:466–82.
  112. 112. Loy BD, O’Connor PJ, Dishman RK. The effect of a single bout of exercise on energy and fatigue states: a systematic review and meta-analysis. Fatigue: Biomedicine, Health & Behavior. 2013;1(4):223–42.
  113. 113. Brown DMY, Graham JD, Innes KI, Harris S, Flemington A, Bray SR. Effects of Prior Cognitive Exertion on Physical Performance: A Systematic Review and Meta-analysis. Sports Med. 2020;50(3):497–529. pmid:31873926
  114. 114. Mehta RK, Parasuraman R. Effects of mental fatigue on the development of physical fatigue: a neuroergonomic approach. Hum Factors. 2014;56(4):645–56. pmid:25029891
  115. 115. Schmit C, Brisswalter J. Executive functioning during prolonged exercise: a fatigue-based neurocognitive perspective. International Review of Sport and Exercise Psychology. 2018;13(1):21–39.
  116. 116. Tanaka M, Ishii A, Watanabe Y. Neural effect of mental fatigue on physical fatigue: a magnetoencephalography study. Brain Res. 2014;1542:49–55. pmid:24505624
  117. 117. Xing X, Zhong B, Luo H, Rose T, Li J, Antwi-Afari MF. Effects of physical fatigue on the induction of mental fatigue of construction workers: A pilot study based on a neurophysiological approach. Automation in Construction. 2020;120:103381.
  118. 118. Hassan EK, Jones AM, Buckingham G. A novel protocol to induce mental fatigue. Behav Res Methods. 2024;56(4):3995–4008. pmid:37537491
  119. 119. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. pmid:2748771
  120. 120. Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res. 2002;42(4):279–85. pmid:11985880